Transcript of Q4 FY25 Earnings Webinar held on Friday, 30th May 2025.
BLACKROSE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Black Rose Industries reported its highest-ever standalone turnover in FY25, up about 21% year-on-year, with revenue growing 20% and EPS up roughly 25% on better cost efficiency and product-mix optimization. The distribution segment led growth with 29% rise in value and 10% in volume, while top five products contributed 85% of revenue and 82% of profit. Manufacturing margins dipped slightly but are being offset by operational efficiencies, renewable energy use and better capacity utilization. Q4 merchant exports softened due to US tariff uncertainty, though management sees this recovering from Q2 onwards. The company unveiled a new R&D facility in Navi Mumbai, is nearing completion of land acquisition and environmental clearance, and announced a feasibility study with Japan's Koei Chemicals for an amine manufacturing unit. The polyacrylamide solid project is on track for pilot stage soon and commercial production by end of FY26 or Q1 FY27, with capex estimated at 60-100 crores.
Positive for shareholders as record revenue, improved margins and a robust expansion pipeline (PAM solid, amine project, new R&D centre) signal healthy growth runway. Near-term export softness due to US tariffs is a watchable risk but domestic demand and new product launches provide a cushion.